Screenshot+2024-04-02+221937.png
Oruka Therapeutics to Present at the 2024 Jefferies Global Healthcare Conference
29 mai 2024 08h00 HE | Oruka Therapeutics, Inc.
WALTHAM, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic...
Screenshot+2024-04-02+221937.png
Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn and Rajiv Panwar
22 mai 2024 08h00 HE | Oruka Therapeutics, Inc.
Joe Senn, PhD, joins as SVP of Nonclinical Research & Development Rajiv Panwar, PhD, joins as VP and Head of Chemistry, Manufacturing, and Controls Appointments strengthen Oruka’s executive...
Screenshot+2024-04-02+221937.png
Oruka Therapeutics Expands Leadership Team, Naming Joana Goncalves, MBChB, as Chief Medical Officer
24 avr. 2024 08h00 HE | Oruka Therapeutics, Inc.
Dr. Goncalves, former CMO at Cara Therapeutics, joins Oruka as CMO Eugenia Levi, PharmD, former Head of Global Medical Affairs for Cosentyx at Novartis, also joins as VP, Medical Affairs ...
Screenshot+2024-04-02+221937.png
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
03 avr. 2024 07h30 HE | Oruka Therapeutics, Inc.
Merger to create a company focused on advancing Oruka’s portfolio of novel biologics that aim to redefine the standard of care for patients with chronic skin diseases Oruka, the third company founded...